Abstract

ObjectivesThe aim of this study was to develop a preoperative positron emission tomography (PET)-based radiomics model for predicting peritoneal metastasis (PM) of gastric cancer (GC).MethodsIn this study, a total of 355 patients (109PM+, 246PM-) who underwent preoperative fluorine-18-fludeoxyglucose (18F-FDG) PET images were retrospectively analyzed. According to a 7:3 ratio, patients were randomly divided into a training set and a validation set. Radiomics features and metabolic parameters data were extracted from PET images. The radiomics features were selected by logistic regression after using maximum relevance and minimum redundancy (mRMR) and the least shrinkage and selection operator (LASSO) method. The radiomics models were based on the rest of these features. The performance of the models was determined by their discrimination, calibration, and clinical usefulness in the training and validation sets.ResultsAfter dimensionality reduction, 12 radiomics feature parameters were obtained to construct radiomics signatures. According to the results of the multivariate logistic regression analysis, only carbohydrate antigen 125 (CA125), maximum standardized uptake value (SUVmax), and the radiomics signature showed statistically significant differences between patients (P<0.05). A radiomics model was developed based on the logistic analyses with an AUC of 0.86 in the training cohort and 0.87 in the validation cohort. The clinical prediction model based on CA125 and SUVmax was 0.76 in the training set and 0.69 in the validation set. The comprehensive model, which contained a rad-score and the clinical factor (CA125) as well as the metabolic parameter (SUVmax), showed promising performance with an AUC of 0.90 in the training cohort and 0.88 in the validation cohort, respectively. The calibration curve showed the actual rate of the nomogram-predicted probability of peritoneal metastasis. Decision curve analysis (DCA) also demonstrated the good clinical utility of the radiomics nomogram.ConclusionsThe comprehensive model based on the rad-score and other factors (SUVmax, CA125) can provide a novel tool for predicting peritoneal metastasis of gastric cancer patients preoperatively.

Highlights

  • Gastric cancer (GC) is the fifth most frequent type of cancer and the third-leading cause of cancer-related death worldwide [1]

  • The clinical prediction model based on carbohydrate antigen 125 (CA125) and maximum standardized uptake value (SUVmax) was 0.76 in the training set and 0.69 in the validation set

  • The calibration curve showed the actual rate of the nomogram-predicted probability of peritoneal metastasis

Read more

Summary

Introduction

Gastric cancer (GC) is the fifth most frequent type of cancer and the third-leading cause of cancer-related death worldwide [1]. East Asia including China still has the highest mortality rate [2]. The prognosis of patients with GC remains poor, and the 5-year overall survival rate is only 40–60% in Asia and 24.5% in Europe [4, 5]. PM is the primary factor leading to the decrease in survival time in patients with GC [6]. Computed tomography (CT) is a common method in the diagnosis of GC, but its sensitivity in the evaluation of PM is low [8]. 18F-fluorodeoxyglucose positron emission tomography/CT (18F-FDG PET/CT) is a powerful, noninvasive tool to evaluate various tumors [9,10,11]. Most imaging information is not visible to the naked eye. Radiomics is an approach that can provide complementary data on imaging

Objectives
Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call